⌘K

Login Start Free

Home/Filings/4/0001615774-18-001258

4//SEC Filing

GRANGE DAVID L 4

Accession 0001615774-18-001258

CIK 0001430306other

View on SEC.gov Company Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:07 PM ET

Size

5.2 KB

Accession

0001615774-18-001258

Insider Transaction Report

Form 4

Period: 2018-02-13

Tonix Pharmaceuticals Holding Corp.TNXP

Director

Transactions

Award
Stock Option
2018-02-13+7,000→ 7,000 total
Exercise: $3.40From: 2019-02-13Exp: 2028-02-12→ Common Stock (7,000 underlying)

Footnotes (1)

[F1]The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan.

Documents

1 file

4
s109088_form4.xmlPrimary
4

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001264908

Filing Metadata

Form type: 4
Filed: Feb 14, 7:00 PM ET
Accepted: Feb 15, 4:07 PM ET
Size: 5.2 KB

View on SEC.gov